share_log

海翔药业:关于2023年度计提资产减值准备的公告

Zhejiang Hisoar Pharmaceutical: Announcement on preparation for impairment of assets accrued in 2023

SZSI ·  Apr 28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more